Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning.

Sztanek F, Lőrincz H, Harangi M, Nagy AC

Open source

DOI
10.1111/dom.71277
Published
2026 Sep 1
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71277,
  title = {Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning.},
  author = {Sztanek F and Lőrincz H and Harangi M and Nagy AC},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.71277},
  url = {https://doi.org/10.1111/dom.71277}
}

RIS

TY  - JOUR
TI  - Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning.
AU  - Sztanek F
AU  - Lőrincz H
AU  - Harangi M
AU  - Nagy AC
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.71277
UR  - https://doi.org/10.1111/dom.71277
ER  - 

APA

F, S., H, L., M, H., & AC, N. (2026). Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71277

Source records